<DOC>
	<DOCNO>NCT01364467</DOCNO>
	<brief_summary>This 14-day , randomize , placebo-controlled , parallel group , mask clinical trial oral guaifenesin therapy Chronic Rhinitis 36 child age 7 18 year . The study investigate effectiveness guaifenesin relief nasal symptom child CRS use sinonasal 5 survey ( SN-5 ) comparison nasal airway volume , biophysical property nasal secretion . The investigator hypothesize Guaifenesin use period 14 day improve subjective nasal complaint pediatric patient chronic rhinitis nasal congestion , measure SN-5 survey compare use placebo . There observed improvement nasal volume cross-sectional area follow use guaifenesin , nasal secretion favorable mucociliary sneeze clearability compare use placebo .</brief_summary>
	<brief_title>The Effect Oral Guaifenesin Pediatric Chronic Rhinitis : A Pilot Study</brief_title>
	<detailed_description />
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Guaifenesin</mesh_term>
	<mesh_term>Phenylpropanolamine</mesh_term>
	<mesh_term>Chlorpheniramine , phenylpropanolamine drug combination</mesh_term>
	<criteria>Children age 7 18 year , diagnose Chronic Rhinitis nasal stuffiness least 3 month duration . Children immunodeficiency , cystic fibrosis , acute subacute symptom , sign bacterial infection , and/or unable cooperate testing exclude . Children document use study medication month evaluation period symptom also exclude .</criteria>
	<gender>All</gender>
	<minimum_age>7 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>